FOR IMMEDIATE RELEASE:
May 29, 2020
Rockville, MD—The Association of Community Cancer Centers (ACCC) is presenting seven abstracts at the American Society of Clinical Oncology 2020 (#ASCO20) Virtual Scientific Program, May 29 to May 31, 2020.
The presentation of data spans across ACCC’s diverse Provider Education portfolio, featuring clinical and non-clinical studies in optimal lung cancer care delivery, comprehensive cancer care services, BRCA testing in patients with breast cancer, and consistent biomarker terminology.
“This incredible work demonstrates ACCC’s growing footprint in precision medicine, as well as a commitment to help elevate the quality of cancer care delivery, access for underserved communities, and improve patient outcomes,” said Randall A. Oyer, MD, ACCC President and Medical Director, Oncology Program, Penn Medicine Lancaster General Health.
“With the impact of COVID-19 on the live meeting in Chicago, we appreciate the opportunity to share this important work virtually with a broader audience,” said Christian G. Downs, JD, MHA, ACCC Executive Director.
SUMMARY OF PRESENTATIONS
[Abstract e14010] An optimal care coordination model for Medicaid patients with lung cancer: Lessons learned from the beta testing phase of a multisite initiative in the United States. Lead Author: Matthew Smeltzer, PhD, University of Memphis, School of Public Health, Memphis, TN
Beta testing helped sites self-assess care delivery and identify areas for improvement in order for Medicaid patients to obtain equity of outcomes with non-Medicaid patients. Review ePublication details.
[Abstract e19195] Improving care for patients with stage III/IV NSCLC: Learnings for multidisciplinary teams from the ACCC national quality survey. Lead Author: Ravi Salgia, MD, PhD, The University of Chicago, Chicago, IL
Multiple opportunities exist to improve the delivery and quality of care for patients with stage III/IV NSCLC, including lowering barriers to effective screening, diagnosis, and care coordination and adhering to evolving standards of care. Explore infographic for survey highlights.
[Abstract e19181] What constitutes high-quality NSCLC care? Overarching quality considerations for improving NSCLC care at US cancer centers. Lead author: Mark A. Socinski, MD, AdventHealth Cancer Institute, Orlando, FL
Recommendations define the criteria for ideal NSCLC care and serve as a valuable resource to guide multidisciplinary practice and quality improvement initiatives. View infographic for specifics on care delivery.
[Abstract 1526] BRCA Testing Concordance with National Guidelines for Patients with Breast Cancer in Community Cancer Programs. Lead Author: Leigh Boehmer, PharmD, BCOP, Association of Community Cancer Centers
Genetic testing is underutilized in this community cohort of women with breast cancer. But opportunities exist to examine facilitators and barriers to community-based genetic services in order to increase access to guideline-based GC/testing. View poster and video takeaways.
[Abstract #1575] Population Genetic Screening for Hereditary Breast and Ovarian Cancer in At-Risk Patients: A Novel Testing and Prevention Model for Community Hospitals Reveals High Mutation Rates Rurally. Lead Author: Charles H. Shelton, MD, Vidant Health, Nags Head, NC
This rural model of screening and prevention of at-risk patients is successful at detecting unknown background germline risks for cancers before they are diagnosed with cancer. Access abstract poster.
[Abstract # 2075] Resource and Reimbursement Barriers to Comprehensive Cancer Care Delivery: An Association of Community Cancer Centers Survey Research Analysis. Lead Author: Al Bowen Benson III, MD, FACP, FASCO, Northwestern Medicine, Chicago, IL
Cancer care centers will need to generate data to inform their true personnel requirements and costs of such with development of external partnerships to systematically link patients with services they cannot provide as a component of their comprehensive care plan for each patient. View poster and video highlights.
[Abstract e24164] Using Consistent Terms in Precision Medicine to Eliminate Patient Confusion. Lead Author: Nikki A. Martin, LUNGevity Foundation, Bethesda, MD
Findings highlight the disparate testing terminology landscape and the need for consistent to reduce patient confusion, improve communication, facilitate shared decision-making and assure concordance in policy development. Review ePublication details.